Published in AIDS on July 06, 2001
Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ (2013) 1.95
Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect (2006) 1.92
Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J (2007) 1.60
HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS (2012) 1.18
Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program. Alcohol Clin Exp Res (2010) 1.13
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users. PLoS One (2012) 1.03
Examining non-AIDS mortality among people who inject drugs. AIDS (2014) 0.98
Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology (2004) 0.90
Increased all-cause and cancer mortality in HTLV-II infection. J Acquir Immune Defic Syndr (2010) 0.87
Characteristics of people who initiate injection drug use later in life. Drug Alcohol Depend (2014) 0.86
A comparative study of mortality among Puerto Rican injection drug users in East Harlem, New York, and Bayamon, Puerto Rico. J Urban Health (2006) 0.86
HIV-associated lung cancer: ambiguities and challenges. AIDS (2012) 0.76
Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections. Math Biosci (2016) 0.75
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet (1991) 2.51
Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35
Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer (2009) 1.89
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer (2006) 1.53
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med (2008) 1.46
HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users. J Acquir Immune Defic Syndr (1991) 1.45
Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer (2013) 1.17
Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr (2001) 1.07
Typhoid fever vaccines. Vaccine (2000) 1.06
HPV-related cancers after solid organ transplantation in the United States. Am J Transplant (2013) 1.03
Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. Br J Cancer (2009) 1.01
Skin cancers associated with autoimmune conditions among elderly adults. Br J Cancer (2010) 1.00
Racial/ethnic differences in cancer risk after kidney transplantation. Am J Transplant (2013) 0.98
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel. J Clin Oncol (2001) 0.95
Effectiveness of a stand-alone aftercare program for drug-involved offenders. J Subst Abuse Treat (2001) 0.93
Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr (1995) 0.90
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties. J Clin Oncol (2001) 0.89
Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med (2001) 0.88
Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period. Br J Cancer (2001) 0.86
Diagnosis and treatment of acute bacterial rhinosinusitis. Evid Rep Technol Assess (Summ) (1999) 0.85
Sirolimus use and cancer incidence among US kidney transplant recipients. Am J Transplant (2014) 0.84
Female-to-male transmission of HIV. JAMA (1992) 0.83
Persistent human herpesvirus 8 viremia associated with coinfection with human T-cell lymphotropic virus type I and myelofibrosis. J Acquir Immune Defic Syndr (2000) 0.82
Absence of human T-cell lymphotropic virus type I and human foamy virus in thymoma. Br J Cancer (2004) 0.80
Introduction to the special issue: treatment process in DATOS. Drug Alcohol Depend (1999) 0.80
Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients. Br J Dermatol (2012) 0.80
Prevention of adolescent drug abuse. Int J Addict (1986) 0.80
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies. J Clin Oncol (2000) 0.79
Community prevention efforts to reduce the spread of AIDS associated with intravenous drug abuse. AIDS Educ Prev (1990) 0.79
Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users. J Infect Dis (1995) 0.78
A study of adult T-cell leukemia/lymphoma incidence in central Brooklyn. Int J Cancer (1999) 0.78
The context and caveats of prevention research on drug abuse. NIDA Res Monogr (1985) 0.78
Tuberculosis testing in correctional officers: a national random survey of jails in the United States. Int J Tuberc Lung Dis (2010) 0.77
The role of cocaine use in the HIV transmission among IVDUs: 1987 and 1988 cohort study. NIDA Res Monogr (1990) 0.76
AIDS-Related opportunistic illness and potent antiretroviral therapy. JAMA (2000) 0.75
Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study. Br J Cancer (2007) 0.75
Symptomless colonisation by Clostridium difficile and risk of diarrhoea. Lancet (1998) 0.75
A solid phase immunofluorescent assay for the measurement of salivary immunoglobulin and albumin levels. J Dent Res (1980) 0.75
Similarity of clients and treatment outcome in outpatient drug-free programs. Am J Drug Alcohol Abuse (1983) 0.75
Overview of drug abuse prevention research. NIDA Res Monogr (1985) 0.75
Implications of etiological research for preventive interventions and future research. NIDA Res Monogr (1985) 0.75
[Cancer and HIV]. Sidahora (2001) 0.75
Symbolic interaction theory: a perspective on drug abuse and its treatment. Int J Addict (1984) 0.75
Human T-cell lymphotropic virus type I infection in Barbados: results of a 20-year follow-up study. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.75
The context of HIV prevention. J Prim Prev (1991) 0.75
Future directions in drug abuse prevention research. NIDA Res Monogr (1985) 0.75
Future directions for studies on the context of HIV risk. NIDA Res Monogr (1994) 0.75
Needle sharing behaviors associated with HIV among intravenous drug users (IVDUs): a two-year study. NIDA Res Monogr (1990) 0.75
Patch testing for vulval symptoms: our experience with 282 patients. Clin Exp Dermatol (2014) 0.75
Factors associated with elevated risk of HIV among Hispanic IVDAs. NIDA Res Monogr (1990) 0.75